Impact of regulatory spin of pioglitazone on prescription of antidiabetic drugs among physicians in India: A multicentre questionnaire-based observational study

BACKGROUND & OBJECTIVES: Pioglitazone was suspended for manufacture and sale by the Indian drug regulator in June 2013 due to its association with urinary bladder carcinoma, which was revoked within a short period (July 2013). The present questionnaire-based nationwide study was conducted to ass...

Descripción completa

Detalles Bibliográficos
Autores principales: Goyal, Aman, Singh, Harmanjit, Sehgal, Vijay Kumar, Jayanthi, C.R., Munshi, Renuka, Bairy, K. Laxminarayana, Kumar, Rakesh, Kaushal, Sandeep, Kakkar, Ashish Kumar, Ambwani, Sneha, Goyal, Chhaya, Mazumdar, Goutameswar, Adhikari, Anjan, Das, Nina, Stephy, Divya John, Thangaraju, Pugazhenthan, Dhasmana, D.C., Rehman, Shakil U., Chakrabarti, Amit, Bhandare, Basavaraj, Badyal, Dinesh Kumar, Kaur, Inderpal, Chandrashekar, K., Singh, Jagjit, Dhamija, Puneet, Sarangi, Sudhir Chandra, Gupta, Yogendra Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5819028/
https://www.ncbi.nlm.nih.gov/pubmed/29434060
http://dx.doi.org/10.4103/ijmr.IJMR_1416_15

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5819028/
https://www.ncbi.nlm.nih.gov/pubmed/29434060
http://dx.doi.org/10.4103/ijmr.IJMR_1416_15

Ejemplares similares